ALVO vs MESO: stock comparison and AI forecast
Alvotech (ALVO) and Mesoblast Ltd (MESO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALVO Alvotech
- Price
- $4.86 +51.9% · 6M
- Market Cap
- $1.73B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MESO Mesoblast Ltd
- Price
- $14.27 -3.6% · 6M
- Market Cap
- $1.83B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ALVO and MESO have similar market capitalizations ($1.73B and $1.83B).
- Over the last six months ALVO returned +51.9% and MESO -3.6%.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALVO | MESO |
|---|---|---|
| Market Cap | $1.73B | $1.83B |
| EPS | $-0.89 | $-0.25 |
| Revenue/Share | $4.54 | $0.61 |
| FCF/Share | $-1.43 | – |
Profitability & Margins
| Metric | ALVO | MESO |
|---|---|---|
| ROA | -14.5% | – |
| ROIC | 18.6% | – |
| Gross Margin | 61.3% | – |
| Operating Margin | 13.6% | – |
| Net Margin | -13.3% | – |
| EBT Margin | -7.8% | -357.5% |
| Tax Rate | -70.1% | -0.3% |
Financial Health
| Metric | ALVO | MESO |
|---|---|---|
| Current Ratio | 1.89x | 1.58x |
| Quick Ratio | 1.16x | 1.41x |
| D/E Ratio | – | 0.36x |
| Financial Leverage | – | 1.36x |
| Working Capital | $270M | $74M |
Cash Flow
| Metric | ALVO | MESO |
|---|---|---|
| Operating Cash Flow | -$345M | -$149M |
| Free Cash Flow | -$510M | – |
| Capital Spending | -$165M | – |
| FCF/Sales | -31.5% | – |
| CapEx/Sales | 10.2% | – |
Operational Efficiency
| Metric | ALVO | MESO |
|---|---|---|
| Asset Turnover | 1.09x | 0.10x |
| Receivables Turnover | – | 1.8x |
| Inventory Turnover | 2.8x | – |
| Fixed Assets Turnover | 4.5x | 43.3x |
| Days Sales Outstanding | – | 204 days |
| Days Inventory | 128 days | – |
| Payables Period | 74 days | – |
Income Statement
| Metric | ALVO | MESO |
|---|---|---|
| Total Revenue | $1.62B | $78M |
| Operating Income | $220M | – |
| Net Income | -$216M | – |
| R&D Expense | $546M | $127M |
| Cost of Goods Sold | $625M | – |
Dividend & Shareholder Information
| Metric | ALVO | MESO |
|---|---|---|
| Shares Outstanding | 356M | 128M |
ALVO vs MESO: stock comparison and AI forecast
Which is bigger, ALVO or MESO?
ALVO and MESO have similar market capitalizations ($1.73B and $1.83B).
Which stock performed better over the last six months, ALVO or MESO?
Over the last six months ALVO returned +51.9% and MESO -3.6%.
Which one does Intratio's AI model rank higher, ALVO or MESO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.